Retatrutide — 10 mg Ships from Ireland
Tracked shipping
Ireland1–2 working days
Europe5–10 working days
Research use only. This product is supplied strictly for in-vitro laboratory research. Not for human or veterinary use.
Research Peptide

Retatrutide

Often studied for
Body weightAppetiteBlood sugarEnergy balance

Preparation: Freeze-dried powder — mixed with bacteriostatic water before research.

Retatrutide is studied in metabolic research for its interaction with three hormone receptors: GLP-1, GIP and glucagon. This combined activity is commonly described as triple agonism.

99.71% purity · 12.24 mgView COA
Uther 0715
99.73% purity · 25.85 mgView COA
Uther 0716
99.83% purity · 35.02 mgView COA
Changsha 26-002
99.69% purity · 40.51 mgView COA
Uther 0602
1
Preparation Essentials
Bacteriostatic Water
Bacteriostatic Water

Commonly used to prepare freeze-dried peptide products.

€20
In stock
Research Starter Pack
Research Starter Pack

Five 1 ml syringes with preparation wipes

€5
In stock

Storage & Preparation

Storage

Store the freeze-dried vial in a standard freezer (-20°C). Once mixed with liquid, keep it in the fridge (2–8°C) and use within 28 days.

Preparation

Supplied as a freeze-dried powder and commonly prepared using bacteriostatic water before research. Add the water slowly down the inside of the vial (not straight onto the powder), then swirl gently — don't shake — until it's fully dissolved. Once mixed, keep it in the fridge and use within the time noted above.
Need help calculating the volume? Open Reconstitution Calculator

Related Compounds

Tirzepatide
Tirzepatide
From €20
Cagrilintide
Cagrilintide
From €35

Research Information

Everything below summarizes the current published research on this compound.

What Is Retatrutide?

Retatrutide is an investigational peptide currently being studied for body weight, appetite and blood sugar in laboratory research. It is supplied as a freeze-dried powder for laboratory and research use only.

Why Is It Being Researched?

Scientists want to know what happens when all three signals are engaged together, instead of separately. It's part of a bigger question in current weight research: does combining these signals lead to different results than targeting just one or two?

Common Research Areas

  • Body weight
  • Appetite
  • Blood sugar
  • Energy balance

In scientific terms, retatrutide is known as a "triple agonist" — it interacts with three hormone receptors: GLP-1, GIP and glucagon. In a Phase 2 human trial published in the New England Journal of Medicine, adults with obesity who received retatrutide by injection over 48 weeks lost substantially more weight than those on a placebo, with the biggest effect at the highest dose tested. A longer Phase 3 trial is reported to be underway. These are trial results, not a guarantee of what would happen for any one person.

Frequently Asked Questions

What's different about retatrutide compared to tirzepatide?

Both are studied for their effect on appetite and blood sugar, but retatrutide works on one extra signal — related to energy and fat burning — that tirzepatide doesn't.

How do I know this batch is the real thing?

Every batch comes with a results certificate showing it passed lab purity testing, matching the numbers listed on this page.

Has retatrutide's effect on weight actually been tested in people?

Yes — a human trial reported meaningful weight loss over 48 weeks, and a longer follow-up trial is reported to be underway. These are trial results, not a promise of any individual outcome.

For research use only.

Our products are supplied for laboratory and in-vitro research and are not intended for human or veterinary use. By ordering, you confirm you're a qualified researcher and will handle the material responsibly.